GLP-1 drugs are shrinking appetites and supercharging demand for nutrient-dense, snackable formats. Precision eating is rewriting menus and appears to be reshaping the future of food, drink, and wellness.
Heavy soda — an ultra-sweet, syrup-heavy twist on fountain drinks — is gaining viral traction and nostalgic appeal. With minimal operational lift, it offers high-margin potential and Gen Z buzz for savvy beverage retailers.
GLP-1 weight-loss drugs are transforming dieting culture, offering a relatively easy solution to weight loss. While these drugs may disrupt food consumption patterns, their long-term impact hinges on overcoming high dropout rates and premium pricing, one industry insider says.
